COMMUNIQUÉS West-GlobeNewswire

Rhythm Pharmaceuticals Announces Presentation of Genetic Epidemiology of LEPR, POMC, And PCSK1 Variants at ENDO 2018

19/03/2018 - 21:01

BOSTON, March 19, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM ), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of [...]

Molecular Templates to Present at the Oppenheimer 28th Annual Healthcare Conference

19/03/2018 - 21:01

AUSTIN, Texas, March 19, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM ) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new [...]

Avinger Announces Fourth Quarter and Full Year 2017 Results

19/03/2018 - 21:01

REDWOOD CITY, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ) (“Avinger” or the “Company”), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported [...]

Emblem Selects No Fixed Address as its Agency of Record

19/03/2018 - 21:00

TORONTO, March 19, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT) (" Emblem " or the " Corporation ") is pleased to announce that it has selected No Fixed Address ( “NFA” ) as its agency of record, [...]

Soricimed annonce la nomination du Dr Marc Rubin et de M. Vaughn Embro-Pantalony à son conseil d’administration

19/03/2018 - 19:38

MONCTON, Nouveau-Brunswick, 19 mars 2018 (GLOBE NEWSWIRE) -- Soricimed Biopharma Inc. (« Soricimed »), compagnie pharmaceutique au stade clinique spécialisée dans la recherche et la mise au point de thérapies contre le [...]

Soricimed Announces the Appointment of Dr. Marc Rubin and Mr. Vaughn Embro-Pantalony to Board of Directors

19/03/2018 - 19:30

MONCTON, New Brunswick, March 19, 2018 (GLOBE NEWSWIRE) -- Soricimed Biopharma Inc. ("Soricimed"), a clinical-stage pharmaceutical company discovering and developing targeted cancer therapeutics, is pleased to announce [...]

Extraordinary General Meeting of Active Biotech AB

19/03/2018 - 19:01

PRESS RELEASE NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR [...]

OSE Immunotherapeutics to Present New Data on OSE-172 at American Association for Cancer Research Annual Meeting 2018, in Chicago, April 14-18

19/03/2018 - 18:00

OSE-172, SIRPa Antagonist: Prevents Metastasis Spread in Aggressive Cancer Models; Decreases Tumor Growth and Suppressive Function of Tumor Myeloid Cells, MDSC and M2 Macrophages, in Various Cancers Models; Potentiates [...]

Transactions under Novozymes’ stock buyback program

19/03/2018 - 17:49

Please read the full announcement in the attached PDF 2018_09_Stock_Buybackprogram_EN

pSivida Announces FDA Acceptance For Filing of New Drug Application (NDA) for Durasert™ Three-Year Treatment for Posterior Segment Uveitis

19/03/2018 - 17:35

WATERTOWN, Mass., March 19, 2018 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ: PSDV ) (ASX:PVA), a leader in the development of sustained release drug products and technologies, today announced that its New Drug [...]

Ossur Hf : Transactions in relation to share buyback program

19/03/2018 - 17:00

Announcement no. 22/2018 Reykjavik, 19 March 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]

NICOX :Document de reference 2017

19/03/2018 - 16:54

Nicox : Document de reference 2017 ................................................ 19 mars 2018 Sophia Antipolis, France Le Document de référence 2017 de la société Nicox SA, incluant le rapport financier annuel visé à [...]

Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation

19/03/2018 - 16:36

DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc (NYSE: MDT) today announced one-year results from the CRYO4PERSISTENT AF study of ablation with the Arctic Front Advance(TM) Cryoballoon to isolate the [...]

Tivity Health to Issue First Quarter 2018 Financial Results After Market Close on April 23

19/03/2018 - 16:00

Nashville, Tenn., March 19, 2018 (GLOBE NEWSWIRE) -- Tivity Health, Inc. (NASDAQ: TVTY) today announced that its financial results for the first quarter ending March 31, 2018, will be released after market close on [...]

Colibri Heart Valve Advances Second-Generation TAVI System into Clinical Feasibility Study

19/03/2018 - 15:52

BROOMFIELD, CO , March 19, 2018 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC , a privately held emerging medical device company, today announced that the first two patients have been successfully enrolled in a clinical [...]

Novo Nordisk A/S - Share repurchase programme

19/03/2018 - 15:30

Bagsværd, Denmark, 19 March 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]

Sales of Olainfarm in February Increase by 33%

19/03/2018 - 15:22

March 19, 2018 Sales of Olainfarm in February Increase by 33% Preliminary consolidated sales results of JSC Olainfarm for February 2018 show that sales have reached 10.69 million euros, which represents an increase by [...]

OncBioMune Appoints Robert Neal Holcomb to Board of Directors

19/03/2018 - 14:23

BATON ROUGE, La., March 19, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]

Abattis Strengthens Regulatory Services Offerings through Partnership with dicentra

19/03/2018 - 14:17

VANCOUVER, British Columbia, March 19, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the " Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to announce it has signed a letter of intent (the " LOI ") [...]